Eryılmaz, I. E. Et Al. 2023. Luteolin disrupts cell health as a pro-oxidant agent against PC-3 metastatic castration-resistant prostate cancer cells. 9th BAU Drug Design Congress , (İstanbul, Turkey), 124.

Eryılmaz, I. E., Çolakoğlu Bergel , C., Huriyet, N., Arıöz, B., Çeçener, G., & Egeli, Ü., (2023). Luteolin disrupts cell health as a pro-oxidant agent against PC-3 metastatic castration-resistant prostate cancer cells . 9th BAU Drug Design Congress (pp.124). İstanbul, Turkey

Eryılmaz, IŞIL Et Al. "Luteolin disrupts cell health as a pro-oxidant agent against PC-3 metastatic castration-resistant prostate cancer cells," 9th BAU Drug Design Congress, İstanbul, Turkey, 2023

Eryılmaz, IŞIL E. Et Al. "Luteolin disrupts cell health as a pro-oxidant agent against PC-3 metastatic castration-resistant prostate cancer cells." 9th BAU Drug Design Congress , İstanbul, Turkey, pp.124, 2023

Eryılmaz, I. E. Et Al. (2023) . "Luteolin disrupts cell health as a pro-oxidant agent against PC-3 metastatic castration-resistant prostate cancer cells." 9th BAU Drug Design Congress , İstanbul, Turkey, p.124.

@conferencepaper{conferencepaper, author={IŞIL EZGİ ERYILMAZ Et Al. }, title={Luteolin disrupts cell health as a pro-oxidant agent against PC-3 metastatic castration-resistant prostate cancer cells}, congress name={9th BAU Drug Design Congress}, city={İstanbul}, country={Turkey}, year={2023}, pages={124} }